Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

5.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.1K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

9.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.7K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

748
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
748
Overview of Microsoft Excel as a Data Analysis Tool01:13

Overview of Microsoft Excel as a Data Analysis Tool

1.6K
Microsoft Excel is a cornerstone tool for data analysis and statistical operations, offering a wide array of functionalities to manage, analyze, and visualize data efficiently. Recognized for its versatility, Excel facilitates the performance of basic to complex statistical operations, serving as an indispensable asset for analysts, researchers, and students alike. Excel's significance in data analysis emanates from its spreadsheet environment, where data can be organized in rows and...
1.6K
Noncompartmental Analysis: Mean Residence Time01:05

Noncompartmental Analysis: Mean Residence Time

600
According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
600

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Empirical Bayes Variational Autoencoder-A Neural ODE Approach for Population Modeling in Pharmacology.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov Model.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Postprandial glucose profiles may reflect heterogeneity in insulin secretion and sensitivity in type 2 diabetes.

Metabolism: clinical and experimental·2026
Same author

MCMC Correction of Score-Based Diffusion Models for Model Composition.

Entropy (Basel, Switzerland)·2026
Same author

Confidence-based prediction of antibiotic resistance at the patient level.

mBio·2026
Same author

Avenanthramides and avenacosides as biomarkers of oat intake: a pharmacokinetic study of solid and liquid oat consumption under single and repeated dose conditions.

Nutrition journal·2025
Same journal

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Pharmacological reviews·2026
Same journal

Mast cell proteases and their significance in physiology, pathology, and therapeutic approaches.

Pharmacological reviews·2026
Same journal

Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research.

Pharmacological reviews·2026
Same journal

Reharnessing the therapeutic potential of gallium-based compounds in oncology: From the laboratory to the clinic.

Pharmacological reviews·2026
Same journal

Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions.

Pharmacological reviews·2026
Same journal

International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.

Pharmacological reviews·2026
See all related articles

Related Experiment Video

Updated: Jan 31, 2026

Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice
08:51

Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice

Published on: May 10, 2019

12.4K

Dose-Response-Time Data Analysis: An Underexploited Trinity.

Johan Gabrielsson1, Robert Andersson2, Mats Jirstrand2

  • 1Division of Pharmacology and Toxicology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden (J.G.); Fraunhofer-Chalmers Centre, Gothenburg, Sweden (R.A., M.J.); Pharmacilitator AB, Vallda, Sweden (S.H.); and Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden (S.H.) johan.gabrielsson@slu.se.

Pharmacological Reviews
|December 28, 2018
PubMed
Summary
This summary is machine-generated.

Analyzing drug effects using only response-time data is a viable alternative to traditional plasma sampling. This pharmacodynamic analysis method bypasses direct drug measurement and is useful in specific patient populations and research settings.

More Related Videos

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K
Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

1.0K

Related Experiment Videos

Last Updated: Jan 31, 2026

Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice
08:51

Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice

Published on: May 10, 2019

12.4K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K
Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

1.0K

Area of Science:

  • Pharmacology
  • Biomedical Engineering
  • Drug Development

Background:

  • Traditional pharmacokinetic and pharmacodynamic (PK/PD) analyses rely on sequential plasma concentration and response-time data.
  • Plasma sampling can be challenging or impossible in certain populations (e.g., intensive care, pediatrics) or research scenarios (e.g., drug discovery).

Purpose of the Study:

  • To explore the utility of response-time data alone for pharmacodynamic analyses.
  • To highlight the potential of biophase functions in characterizing drug response and optimizing study protocols.
  • To review the application of dose-response-time (DRT) modeling in preclinical and clinical studies.

Main Methods:

  • Focusing on response-time data to infer pharmacokinetic and pharmacodynamic parameters.
  • Utilizing biophase functions to analyze drug turnover, biophase kinetics, potency, and efficacy.
  • Reviewing literature on the application of DRT modeling.

Main Results:

  • Response-time data can adequately characterize pharmacodynamic properties without direct drug concentration measurements.
  • This approach is valuable when plasma sampling is impractical or uninformative.
  • DRT modeling can be optimized by careful consideration of dose selection, dosing frequency, and administration routes.

Conclusions:

  • Pharmacodynamic analyses using solely response-time data offer a robust alternative to conventional PK/PD methods.
  • Biophase functions provide critical insights into drug behavior at the target site.
  • Further investigation and application of DRT modeling are warranted, particularly in challenging clinical and preclinical settings.